Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease–Free Survival, and Mortality Risk

Authors:

Abstract
Lipoprotein(a) (Lp[a]) consists of a low-density lipoprotein attached to apolipoprotein(a) by a disulfide bond. Plasma levels of Lp(a) are associated with a higher risk of a broad range of atherosclerotic cardiovascular disease (CVD).1-5 The evidence linking Lp(a) levels and Lp(a)-raising genetic variants with all-cause mortality is not as consistent. A 1998 study of healthy centenarian individuals initiated a debate about the potential association between Lp(a) and longevity following the report that up to one-quarter of that population had high Lp(a) levels in the absence of any atherosclerotic CVD.6 Another study of patients with documented coronary heart disease found no evidence of an association between high Lp(a) levels and all-cause mortality.7 A recently published study by Langsted et al8 revealed an association between high Lp(a) levels and cardiovascular and all-cause mortality in the general Danish population. This association could be owing to the fact that individuals with high Lp(a) levels are typically characterized by a smaller apolipoprotein(a) isoform size.

This publication has 28 references indexed in Scilit: